Form 13-F position report

SAREPTA THERAPEUTICS INC

Reported by Cambridge Investment Research Advisors Inc

SRPT 1.25 09/15/27 CUSIP 803607AD2 Manager CIK 0001419186

Reported 21,000 shares, up 8,000 (61.5%) from the prior quarter.

Reported value 66.7%; share count 61.5% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 21,000 Quarter-end amount reported
Reported value $20,000 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-03-31 12000
2026-06-30 12000
2026-09-30 20000

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for SAREPTA THERAPEUTICS INC held by Cambridge Investment Research Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 21,000 +8,000 (61.5%) < 0.01% $20,000 2026-11-02
Q2 2026 Unchanged 13,000 0 (0.0%) < 0.01% $12,000 2026-07-27
Q1 2026 New 13,000 +13,000 (0.0%) < 0.01% $12,000 2026-04-30

Who else reported the position

23 managers reported SAREPTA THERAPEUTICS INC for Q3 2026.

Managers reporting SAREPTA THERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
HIGHBRIDGE CAPITAL MANAGEMENT LLC Unchanged 52,306,000 0 1.12% $50,344,525 13 qtrs
DeepCurrents Investment Group LLC Unchanged 17,245,000 0 0.47% $16,530,776 2 qtrs
D E Shaw & Co Inc Unchanged 16,897,000 0 < 0.01% $16,231,408 6 qtrs
Calamos Advisors LLC Unchanged 15,000 0 0.04% $14,384,550 13 qtrs
BROOKFIELD CORPORATION New 12,115,000 +12,115,000 0.01% $11,660,186 1 qtr
CORBYN INVESTMENT MANAGEMENT INC MD Reduced 10,810,000 -67,000 3.09% $10,377,153 3 qtrs
Russell Investments Group Ltd Added 6,036,000 +2,861,000 < 0.01% $5,791,711 2 qtrs
Chicago Capital Management LLC Added 4,265 +1,095 3.72% $4,107,432 2 qtrs
BNP Paribas Asset Management Holding S A Added 3,500,000 +3,475,346 < 0.01% $3,340,469 11 qtrs
FMR LLC Unchanged 0 0 < 0.01% $1,434,178 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 02, 2026
Filing type
13F-HR
Position type
INC NOTE 1.250 9/1

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.